LFTD Partners Inc.
LIFD- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001391135
No open-market purchases or sales by LFTD Partners Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by LFTD Partners Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for LFTD Partners Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jacobs Gerard M. | CEO | 1,063,448 | Nov 21, 2023 | 0 |
| Mesolella Vincent J | Director | 537,862 | Oct 5, 2021 | 0 |
| Morrissy Richard Emmet | Director | 30,000 | Oct 5, 2021 | 0 |
| Bloom Joshua A | Director | 55,000 | Oct 5, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 (view filing) | Nov 15 | 6 days | Jacobs Gerard M.CEO | PPurchase | +375 | $1.50 | +$562.5 | 0.0%1.06M after | Amended |